Evidence map›Paper›PMID 28836620›Full record

ReviewNature reviews. Cardiology2018

Future of transcatheter aortic valve implantation - evolving clinical indications.

Rishi Puri, Chekrallah Chamandi, Tania Rodriguez-Gabella, Josep Rodés-Cabau

Registry-linked trialAbstract readReview
PubMed Publisher
In one paragraph

Review in Nature reviews. Cardiology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT04139616 (Prospective Validation of a Pre-Specified Algorithm for the Management of Conduction Disturbances Following Transcatheter Aortic Valve Replacement. The PROMOTE Study), which is not on this map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT04139616 recruitingnot on this mapstarted 2020, after this paper: background citation

Prospective Validation of a Pre-Specified Algorithm for the Management of Conduction Disturbances Following Transcatheter Aortic Valve Replacement. The PROMOTE Study

Typeobservational_patient_registrySponsorCentre de Recherche de l'Institut Universitaire de Cardiologie et de Pneumologie de QuebecRan2020 to 2027Enrolled2,000ConditionsConduction Disturbances, Transcatheter Aortic Valve Replacement, Permanent Pacemaker Implantation
3 · Its place in the literature

Who cites it

12 citing papers in PubMed.

  1. Review
  2. Article
  3. Impact ofJournal of clinical medicine · 2023
    Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Review
  10. TAVR versus surgery in low-risk patients.Nature reviews. Cardiology · 2019
    Article
  11. TAVI for Pure Native Aortic Regurgitation: Are We There Yet?Interventional cardiology (London, England) · 2019
    Review
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Rishi PuriQuébec Heart & Lung Institute, Laval University, 2725 Chemin Ste-Foy, Québec City, Québec G1V 4G5, Canada; at the Cleveland Clinic Coordinating Center for Clinical Research (C5R), 9500 Euclid Avenue, Cleveland, Ohio 44195, USA; and at the Department of Medicine, University of Adelaide, North Terrace Campus, Adelaide, South Australia 5005, Australia.
Chekrallah ChamandiQuébec Heart & Lung Institute, Laval University, 2725 Chemin Ste-Foy, Québec City, Québec G1V 4G5, Canada.
Tania Rodriguez-GabellaQuébec Heart & Lung Institute, Laval University, 2725 Chemin Ste-Foy, Québec City, Québec G1V 4G5, Canada.
Josep Rodés-CabauQuébec Heart & Lung Institute, Laval University, 2725 Chemin Ste-Foy, Québec City, Québec G1V 4G5, Canada.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Accumulating clinical experience and technological improvements have provided the basis for transcatheter aortic valve implantation (TAVI) to emerge as a well-established means for treating patients with severe symptomatic aortic stenosis at high or prohibitive surgical risk. During this decade, TAVI has emerged as a valid alternative to surgical aortic valve replacement in patients at intermediate surgical risk, and several studies are currently being performed to evaluate the role of TAVI in patients at low surgical risk. Furthermore, promising, but preliminary, data are emerging on the efficacy of TAVI for treating patients with bicuspid aortic valve disease, as well as patients with pure aortic regurgitation. In this Perspectives article, we summarize the evolving indications for TAVI, and give our opinion on the future perspectives for this procedure.

Indexed as

Transcatheter Aortic Valve ReplacementAortic Valve InsufficiencyAortic Valve StenosisCardiovascular Surgical ProceduresForecastingHumans

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.